首页> 外文期刊>Journal of pharmaceutical sciences. >Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides.
【24h】

Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides.

机译:聚乙二醇和D肽的口服生物利用度反映了旁细胞途径中大小区分的物种差异。

获取原文
获取原文并翻译 | 示例
           

摘要

Animal models are frequently used to aid prediction of intestinal absorption in humans. However, there is little comparative quantitative information on species differences in paracellular permeation, which is an important route for oral absorption of small to medium-sized hydrophilic drug molecules. This study addresses this issue by comparing the molecular mass (MM) dependency in oral bioavailability between rat and dog of poly(ethylene glycol) (PEG), a polydispersed model mixture commonly used to characterize paracellular absorption, and of a series of eight D-peptides (based on D-phenylalanine). Fasted rats and dogs received PEG (400/900) and the D-peptides (MM 236-406 Da), orally and intravenously, with total 24-48 h urine collection to estimate oral bioavailability. After HPLC separation, the individual PEG oligomers and D-peptides were determined using radiometric detection, for radiolabeled material, and LC-MS, for unlabeled (PEG) material. All compounds were predominantly excreted unchanged following intravenous administration. After oral administration, the predominant peak in the radiochromatogram was unchanged material, indicating stability of the compounds in the gastrointestinal tract. A clear molecular mass dependency in oral bioavailability was seen with both series, but with absorption much greater in dog than rat. Thus, for PEG in rat, bioavailability decreased sharply from 79 to around 2% with increasing MM between 282 and 591 Da, and then tapered to around 1. 5% up to 1295 Da. Whereas in dog, bioavailability remained around 100% for oligomers up to 600 Da and then decreased quite sharply with increasing MM, tending to plateau around 13% beyond 900 Da. Likewise, for the d-peptides in rat, bioavailability decreased from 30 to 1% with increasing MM between 236 and 406 Da, whereas in dog it was 100%, declining to 16% over the same molecular range. This species difference appears to be due to a larger pore size and greater frequency of pores in the paracellular pathway of dog compared to rat. Furthermore, on the basis of comparison with literature data for PEG and selected drugs, rat would appear to be a better predictor than dog of absorption of hydrophilic compounds in human.
机译:动物模型通常用于辅助人类肠道吸收的预测。然而,关于细胞旁渗透中物种差异的比较定量信息很少,这是口服吸收中小型亲水性药物分子的重要途径。这项研究通过比较大鼠和狗之间的分子质量(MM)依赖性,研究了聚乙二醇(PEG),通常用于表征细胞旁吸收的多分散模型混合物以及一系列八个D-的大鼠之间的口服生物利用度肽(基于D-苯丙氨酸)。禁食的大鼠和狗口服和静脉内接受PEG(400/900)和D肽(MM 236-406 Da),总共收集24-48 h尿液以评估口服生物利用度。 HPLC分离后,对于放射标记的材料,使用放射检测确定单个PEG低聚物和D肽,对于未标记的(PEG)材料,使用LC-MS确定。静脉内给药后,所有化合物主要以不变的方式排泄。口服后,放射色谱图中的主要峰是未改变的物质,表明化合物在胃肠道中的稳定性。在两个系列中均观察到明显的分子量依赖性对口服生物利用度的影响,但在狗中的吸收远大于大鼠。因此,对于大鼠中的PEG,随着282至591 Da之间MM的增加,生物利用度从79%急剧下降至2%左右,然后逐渐下降至1295 Da的1.5%左右。而在狗中,高达600 Da的低聚物的生物利用度保持在100%左右,然后随着MM的增加而急剧下降,在超过900 Da时趋于稳定在13%左右。同样,对于大鼠中的d肽,随着236至406 Da之间MM的增加,生物利用度从30%下降至1%,而狗则为100%,在相同分子范围内下降至16%。与大鼠相比,这种物种差异似乎是由于狗的旁细胞途径中的较大孔径和较高的孔频率所致。此外,根据与PEG和选定药物的文献数据比较,大鼠似乎比狗吸收人体中的亲水性化合物更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号